Morwin Biopharma Private Limited

Morwin Biopharma Private Limited - trading in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
CIN U24232MP2012PTC028249 Incorporated 23 April 2012 ROC Gwalior HQ Indore, Madhya Pradesh, India
Active Private Limited Company trading
Revenue · FY 2022
₹18.62 Lakh
▼ 37% YoY
Net loss · FY 2022
₹2,840
Net margin -0.2%
EBITDA · FY 2022
₹16,703
EBITDA margin 0.9%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
14 yrs
Est. 2012
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Morwin Biopharma Private Limited

Data last updated:

Morwin Biopharma Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 23 April 2012 and has been in existence for over 14 years.

The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP2012PTC028249. Its GSTIN is 23AAJCM2889F1ZA (Madhya Pradesh).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ankit Khandelwal and Ankita Khandelwal.

Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at 103 Sun Enclave 3/1 Manoramaganj, Indore, Madhya Pradesh, India – 452001.

As per the financials filed for FY 2022, the company reported a revenue of ₹18.62 Lakh, a decline of 37% compared to the previous year. For the same year it recorded a net loss of ₹2,840 (net margin -0.2%) and EBITDA of ₹16,703 (EBITDA margin 0.9%). Revenue has grown at a compounded annual rate (CAGR) of 34% over three years and 60% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24232MP2012PTC028249
Registration Number 028249
Incorporation Date 23 April 2012
ROC Gwalior
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Morwin Biopharma Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    103 Sun Enclave 3/1 Manoramaganj, Indore, Madhya Pradesh, India – 452001
  • Industry
    Trading, Other Wholesale, Wholesale

To see the full contact details of Morwin Biopharma Private Limited, buy the company report.

Comprehensive company report
Morwin Biopharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Morwin Biopharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Morwin Biopharma Private Limited, buy the company report.

Financials of Morwin Biopharma Private Limited

FY 2022 filings available

Morwin Biopharma Private Limited reported revenue of ₹18.62 Lakh (down 37% YoY) for FY 2022.

Revenue · FY 2022
₹18.62 Lakh ▼ 37%
Net loss · FY 2022
₹2,840 margin -0.2%
EBITDA · FY 2022
₹16,703 margin 0.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 37%
3 years · compounded
▲ 34%
5 years · compounded
▲ 60%
EBITDA CAGR growth
1 year
▼ 36%
3 years · compounded
▲ 51%
5 years · compounded
▲ 53%

Revenue fell 37% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 60%. EBITDA fell 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹16,703
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹2,840
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profitability
EBITDA Margin0.9%
Net Profit Margin-0.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Morwin Biopharma Private Limited, buy the company report.

Board of directors of Morwin Biopharma Private Limited

Morwin Biopharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ankit KhandelwalDirector23 Apr 201214 Years 6 MonthsCurrent
Ankita KhandelwalDirector26 Oct 20215 Years 0 MonthsCurrent

Peer comparison

Morwin Biopharma Private Limited is compared with the 3 companies closest to it by revenue in the Biotechnology industry (Biopharma), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Jagdamba Biopharma Private Limited₹41.04 Lakh (FY 2019)12.0%Meerut, Uttar Pradesh, India
Morwin Biopharma Private Limitedthis company₹18.62 Lakh (FY 2022)-₹2,840-0.2%-37.0%Indore, Madhya Pradesh, India
Sairen Biopharma Private Limited₹14.08 Lakh (FY 2024)104.0%Pune, Maharashtra, India
Qantas Biopharma Private Limited₹7.54 Lakh (FY 2024)36.0%Hisar, Haryana, India

To see the full peer comparison of Morwin Biopharma Private Limited, buy the company report.

Auditor

Morwin Biopharma Private Limited is audited by VASANT TARAY & CO. for the financial year 2017.

Auditor firmFinancial yearFirm registration number
VASANT TARAY & CO.FY 2017006434C

Shareholding

The shareholding of Morwin Biopharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Morwin Biopharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Morwin Biopharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Morwin Biopharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
23AAJCM2889F1ZAMadhya PradeshActive16 Jul 2017

To see the full GST registrations and return filing status of Morwin Biopharma Private Limited, buy the company report.

Recent activity

Morwin Biopharma Private Limited has 5 board changes on record since 2012: 2 appointments and 3 cessations. The latest: Ankita Khandelwal ceased to be Additional Director on 03 May 2022.

AGM
Morwin Biopharma Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Ceased
Ankita Khandelwal ceased to be Additional Director.
Filing
Morwin Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Gwalior.
Appointed
Ankita Khandelwal was appointed as Director.
Ceased
Ruchi Goyal ceased to be Director.
Ceased
Dharmendra Rajendra Khandelwal ceased to be Director.
Appointed
Ankit Khandelwal was appointed as Director.
Incorporation
23 Apr 2012
Morwin Biopharma Private Limited was registered on 23 Apr 2012 with Roc Gwalior & aged 14 years 6 months as per MCA records.

Frequently asked questions

Morwin Biopharma is an active private limited company based in Indore, Madhya Pradesh, India. The company works in other wholesale, within the trading industry. It was incorporated on 23 April 2012 (14+ years old) and is registered under CIN U24232MP2012PTC028249.

Morwin Biopharma has 2 current directors:

The latest financial statements of Morwin Biopharma on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from 2015 are in the company report.

The GSTIN of Morwin Biopharma is 23AAJCM2889F1ZA, registered in Madhya Pradesh.

The CIN (Corporate Identification Number) of Morwin Biopharma is U24232MP2012PTC028249. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Morwin Biopharma was incorporated on 23 April 2012, making it 14+ years old. It is registered with the Registrar of Companies, Gwalior.

The peers of Morwin Biopharma by revenue are Jagdamba Biopharma Private Limited, Sairen Biopharma Private Limited, Qantas Biopharma Private Limited, all in the Biotechnology industry (Biopharma), with the same principal business activity (wholesale trading).

Ankita Khandelwal ceased to be Additional Director on 03 May 2022. Ankita Khandelwal was appointed as Director on 26 Oct 2021. Ruchi Goyal ceased to be Director on 04 Aug 2020. Morwin Biopharma has 5 board changes on record in total.

The registered office of Morwin Biopharma is at 103 Sun Enclave 31 Manoramaganj, Indore, Madhya Pradesh, India – 452001.

Morwin Biopharma operates in the trading industry, in the other wholesale segment.

The compliance status of Morwin Biopharma is compliant as of 21 September 2026. The company is actively filing with the Registrar of Companies.